Filing Details
- Accession Number:
- 0001144204-13-017341
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-25 18:04:08
- Reporting Period:
- 2013-03-21
- Filing Date:
- 2013-03-25
- Accepted Time:
- 2013-03-25 18:04:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1335103 | Protea Biosciences Group Inc. | NONE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
932267 | T Josiah Austin | 4673 Christopher Place Dallas TX 75204 | Yes | No | Yes | No | |
1319763 | El Coronado Holdings, Llc | 4673 Christopher Place Dallas TX 75204 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-21 | 1,370,000 | $0.50 | 3,506,044 | No | 4 | P | Indirect | As Managing Member of El Coronado Holdings, LLC |
Common Stock | Acquisiton | 2013-03-21 | 1,370,000 | $0.50 | 3,506,044 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | As Managing Member of El Coronado Holdings, LLC |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2013-03-21 | 1,027,500 | $0.00 | 1,027,500 | $1.10 |
Common Stock | Warrant | Acquisiton | 2013-03-21 | 1,027,500 | $0.00 | 1,027,500 | $1.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,065,000 | 2013-03-21 | 2018-03-21 | No | 4 | P | Indirect |
3,065,000 | 2013-03-21 | 2018-03-21 | No | 4 | P | Direct |
Footnotes
- On March 21, 2013 (the "Issue Date"), Protea Biosciences Group, Inc. (the "Company") issued 1,370,000 shares (the "Shares") of common stock, par value $0.0001 per share (the "Common Stock") and warrants (the "Warrants") to purchase 1,027,500 shares of Common Stock to El Coronado Holdings, LLC (the "Holder"), at a purchase price of $0.50 per share , , for an aggregate amount of $685,000. Josiah Austin is a director of the Company and the managing member of the Holder with voting and investment control over the securities of the Company owned of record by the Holder and therefore deemed to beneficially own the securities of the Company owned of record by the Holder.
- Represents the shares of common stock or warrants to purchase shares of common stock of the Company owned of record by El Coronado Holdings, LLC.
- The Warrants are exercisable at an exercise price of $1.10 per share anytime after the Issue Date until the earlier of (i) a Qualified Public Offering (as defined in the Warrant) or (ii) 5:00 p.m. EST on the fifth anniversary of the Issue Date. As set forth in the Warrant, the term "Qualified Public Offering" means the closing of a firm commitment underwritten offering pursuant to an effective registration statement under the Securities Act of 1933, as amended covering the offer and sale of Common Stock for the account of the Company in which the net cash proceeds to the Company (after deduction of underwriting discounts and commissions) are at least $10,000,000. Josiah Austin is the managing member of the Holder with voting and investment control over the securities of the Company owned of record by the Holder and therefore deemed to beneficially own the securities of the Company owned of record by the Holder.
- Represents outstanding warrants to purchase an aggregate of 2,627,500 shares of Common Stock and 437,500 shares of Common Stock underlying an outstanding convertible promissory note in an aggregrate principal amount equal to $125,000.